Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2021 - 10 - 12

Antibiotic-resistance: Welcome to the "Infection in Focus" website

Menarini’s disease awareness project starts with endorsement from the Italian Society for Anti-Infective Treatment (Società Italiana di Terapia Antinfettiva Antibatterica-Antivirale-Antifungina, SITA) 



The goal of the new "Infection in Focus" website, created by Menarini, is to raise awareness about the value of antibiotics, antimicrobial resistance, and  the importance of managing and fighting potentially life-threatening bacterial infections. It also aims to shine a light on patient and caregiver stories, which often remain untold. This is the goal of "Infection in Focus", the new website created by Menarini with the endorsement from the Italian Society for Anti-Infective Treatment (Società Italiana di Terapia Antinfettiva Antibatterica-Antivirale-Antifungina, SITA).

Since the discovery of penicillin, antibiotics have aided the progression and development of medicine and surgery.  Organ transplantation, chemotherapy and complex surgery are possible thanks to the availability of these drugs. However, the emergence of multi-drug resistant pathogens poses a significant threat to global health. Worldwide, 700,000 people die every year as a result of antimicrobial resistance (AMR). The World Health Organization estimates that by 2050, infections caused by multidrug-resistant germs will cause 10 million deaths a year if immediate action is not taken.

Because of AMR, even mild infections may have life threatening consequences, routine medical procedures could become too risky and serious infections may become difficult to treat. Cancer patients are the most at risk from superbugs: certain types of cancer, like multiple myeloma and acute leukaemia, often require antibiotics during the course of treatment to safeguard the progress made by the initial therapy.

The "Infection in Focus" website aims to highlight the importance of AMR, the threat posed by the phenomenon that is antibiotic-resistance, and the importance of conscious use of antibiotics. The multi-media contents are available in Italian and English, with fact sheets and frequently asked questions.

“With this new project, Menarini is once again close to patients, their families and doctors. – as said by Lorenzo Melani, Global Medical and Pharmacovigilance Director, Menarini. - Our hope is that everyone can receive correct information on the threat posed by multidrug-resistant germs and recognize the life-saving role of antibiotics, remembering that in Europe alone, superbugs cause every year about 30,000 victims ".

Visit the website at: